Next Article in Journal
BECLIN1: Protein Structure, Function and Regulation
Next Article in Special Issue
The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
Previous Article in Journal
Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
Previous Article in Special Issue
Muscle Homeostasis and Regeneration: From Molecular Mechanisms to Therapeutic Opportunities
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy

by
Lorenzo Maggi
1,*,
Silvia Bonanno
1,
Concetta Altamura
2 and
Jean-François Desaphy
2
1
Neuroimmunology and Neuromuscular Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy
2
Department of Biomedical Sciences and Human Oncology, School of Medicine, University of Bari Aldo Moro, 70124 Bari, Italy
*
Author to whom correspondence should be addressed.
Cells 2021, 10(6), 1521; https://doi.org/10.3390/cells10061521
Submission received: 4 May 2021 / Revised: 3 June 2021 / Accepted: 10 June 2021 / Published: 16 June 2021

Abstract

Skeletal muscle ion channelopathies (SMICs) are a large heterogeneous group of rare genetic disorders caused by mutations in genes encoding ion channel subunits in the skeletal muscle mainly characterized by myotonia or periodic paralysis, potentially resulting in long-term disabilities. However, with the development of new molecular technologies, new genes and new phenotypes, including progressive myopathies, have been recently discovered, markedly increasing the complexity in the field. In this regard, new advances in SMICs show a less conventional role of ion channels in muscle cell division, proliferation, differentiation, and survival. Hence, SMICs represent an expanding and exciting field. Here, we review current knowledge of SMICs, with a description of their clinical phenotypes, cellular and molecular pathomechanisms, and available treatments.
Keywords: ion channels; myotonia; periodic paralysis; myopathies; SCN4A; CACNA1S; CLCN1; KCNJ2 ion channels; myotonia; periodic paralysis; myopathies; SCN4A; CACNA1S; CLCN1; KCNJ2

Share and Cite

MDPI and ACS Style

Maggi, L.; Bonanno, S.; Altamura, C.; Desaphy, J.-F. Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy. Cells 2021, 10, 1521. https://doi.org/10.3390/cells10061521

AMA Style

Maggi L, Bonanno S, Altamura C, Desaphy J-F. Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy. Cells. 2021; 10(6):1521. https://doi.org/10.3390/cells10061521

Chicago/Turabian Style

Maggi, Lorenzo, Silvia Bonanno, Concetta Altamura, and Jean-François Desaphy. 2021. "Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy" Cells 10, no. 6: 1521. https://doi.org/10.3390/cells10061521

APA Style

Maggi, L., Bonanno, S., Altamura, C., & Desaphy, J.-F. (2021). Ion Channel Gene Mutations Causing Skeletal Muscle Disorders: Pathomechanisms and Opportunities for Therapy. Cells, 10(6), 1521. https://doi.org/10.3390/cells10061521

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop